Patents Assigned to Innovata Limited
  • Surgical compositions for reducing the incidence of adhesions
    Patent number: 8642574
    Abstract: A method of preventing or reducing the incidence of post-operative adhesions in or associated with a body cavity, which comprises introducing into the body cavity a composition containing an aqueous solution or suspension or gel formulation containing the polysaccharide dextrin.
    Type: Grant
    Filed: November 17, 2011
    Date of Patent: February 4, 2014
    Assignee: Innovata Limited
    Inventor: Colin Brown
  • Dextrin containing compositions for prevention of adhesions
    Patent number: 8455464
    Abstract: A composition for the treatment of adhesions that are formed as a result of an inflammatory response comprising an aqueous formulation containing the polysaccharide dextrin in an effective amount. The invention also discloses a method of treating adhesions that are formed as a result of an inflammatory response.
    Type: Grant
    Filed: January 19, 2001
    Date of Patent: June 4, 2013
    Assignee: Innovata Limited
    Inventor: Susan Conroy
  • Dextrin-containing composition for preventing surgical adhesions
    Patent number: 8158610
    Abstract: A method of reducing the incidence of post-operative adhesions in or associated with a body cavity, which comprises introducing into the body cavity a composition containing an aqueous solution or suspension or gel formulation containing the polysaccharide dextrin.
    Type: Grant
    Filed: May 7, 2010
    Date of Patent: April 17, 2012
    Assignee: Innovata Limited
    Inventor: Colin Brown
  • Surgical compositions for reducing the incidence of adhesions
    Patent number: 8063027
    Abstract: A method of preventing or reducing the incidence of post-operative adhesions in or associated with a body cavity, which comprises introducing into the body cavity a composition containing an aqueous solution or suspension or gel formulation containing the polysaccharide dextrin.
    Type: Grant
    Filed: October 25, 2005
    Date of Patent: November 22, 2011
    Assignee: Innovata Limited
    Inventor: Colin Brown
  • COMPOSITION
    Publication number: 20100316724
    Abstract: The invention provides microparticles comprising an immunosuppressant, such as tacrolimus, sirolimus, pimecrolimus, ciclosporin, everolimus or a derivative thereof, and optionally a pharmaceutically acceptable excipient or carrier, such as a saccharide, amino acid, a sugar alcohol or a mixture thereof, and having a median geometric diameter of less than, or equal to, about 10 ?m and which have a tap density of less than or equal to about 0.3 g/cm3.
    Type: Application
    Filed: May 11, 2010
    Publication date: December 16, 2010
    Applicant: Innovata Limited
    Inventors: Nicola Kim Whitfield, Glen Patrick Martyn, Fiona Kirsty Dey, Peter Travers Crew
  • Surgical compositions and methods of using the same
    Patent number: 7732428
    Abstract: A method of preventing or reducing the incidence of post-operative adhesions in or associated with a body cavity, which comprises introducing into the body cavity a composition containing an aqueous solution or suspension or gel formulation containing the polysaccharide dextrin.
    Type: Grant
    Filed: May 13, 1999
    Date of Patent: June 8, 2010
    Assignee: Innovata Limited
    Inventor: Colin Brown
  • Enzyme-prodrug therapy for prosthetic joint repair
    Patent number: 7674454
    Abstract: The invention relates to the use of gene therapy in the treatment of aseptic loosening of orthopaedic prostheses and discloses methods of refixing such prostheses without open revision surgery. In particular, it provides adenoviral vectors and prodrugs for simultaneous, separate or sequential use in the destruction of interface tissue allowing subsequent recementing of loose prostheses in a minimally invasive manner.
    Type: Grant
    Filed: March 4, 2005
    Date of Patent: March 9, 2010
    Assignees: Innovata Limited, Academisch Ziekenhuis Leiden
    Inventors: Tom J. W. Huizinga, Robert C. Hoeben, Rob G. H. H. Nelissen, Andrew Mountain
  • Nucleic acid delivery
    Patent number: 7462351
    Abstract: The present invention provides formulations and methods to enhance the delivery of nucleic acids to cells. Formulations comprising dextrin polymers in combination with sugars provide enhanced delivery of nucleic acids, particularly eucaryotic expression vectors, demonstrate enhanced delivery of nucleic acids to cells in vivo. The present invention also provides methods of treatment in combination with such formulations.
    Type: Grant
    Filed: May 25, 2006
    Date of Patent: December 9, 2008
    Assignees: Canji, Inc., Innovata Limited
    Inventors: Susan E. Conroy, Heidrun Engler, Daniel C. Maneval